These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32413384)

  • 1. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
    Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
    Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells.
    Aiello A; Bacci L; Re A; Ripoli C; Pierconti F; Pinto F; Masetti R; Grassi C; Gaetano C; Bassi PF; Pontecorvi A; Nanni S; Farsetti A
    Sci Rep; 2016 Dec; 6():38414. PubMed ID: 27922078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
    Wang M; Ying J; Zhang M; Liang CZ
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
    Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
    Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.
    Bacci L; Aiello A; Ripoli C; Loria R; Pugliese D; Pierconti F; Rotili D; Strigari L; Pinto F; Bassi PF; Mai A; Grassi C; Pontecorvi A; Falcioni R; Farsetti A; Nanni S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
    Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
    Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
    Chakravarty D; Sboner A; Nair SS; Giannopoulou E; Li R; Hennig S; Mosquera JM; Pauwels J; Park K; Kossai M; MacDonald TY; Fontugne J; Erho N; Vergara IA; Ghadessi M; Davicioni E; Jenkins RB; Palanisamy N; Chen Z; Nakagawa S; Hirose T; Bander NH; Beltran H; Fox AH; Elemento O; Rubin MA
    Nat Commun; 2014 Nov; 5():5383. PubMed ID: 25415230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer.
    Chang YT; Lin TP; Tang JT; Campbell M; Luo YL; Lu SY; Yang CP; Cheng TY; Chang CH; Liu TT; Lin CH; Kung HJ; Pan CC; Chang PC
    Cancer Lett; 2018 Oct; 433():43-52. PubMed ID: 29944905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
    Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
    Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.